Epitope mapping of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) and canine leishmaniasis diagnosis using a derived synthetic bi-epitope

Autor: Fernanda Costal-Oliveira, Ricardo Toshio Fujiwara, Carlos Chávez-Olórtegui, Oscar Bruna-Romero, Eric Henrique Roma, Cristina Monerat Toledo-Machado, T.M. Mendes, Daniella Castanheiras Bartholomeu, Lucas de Carvalho Dhom-Lemos
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Proteomics
B Cells
Physiology
Protozoan Proteins
Antibodies
Protozoan

Biochemistry
Epitope
White Blood Cells
0302 clinical medicine
Animal Cells
Immune Physiology
Zoonoses
Canine leishmaniasis
Medicine and Health Sciences
Dog Diseases
Enzyme-Linked Immunoassays
Leishmania infantum
Leishmaniasis
Mammals
Immune System Proteins
biology
lcsh:Public aspects of medicine
Chemical Synthesis
Infectious Diseases
Vertebrates
Epitopes
B-Lymphocyte

Leishmaniasis
Visceral

Cellular Types
Research Article
Neglected Tropical Diseases
lcsh:Arctic medicine. Tropical medicine
Biosynthetic Techniques
Virulence Factors
lcsh:RC955-962
Immune Cells
030231 tropical medicine
Immunology
Leishmania donovani
Antigens
Protozoan

Enzyme-Linked Immunosorbent Assay
Research and Analysis Methods
Peptide Mapping
Antibodies
03 medical and health sciences
Dogs
Antigen
medicine
Parasitic Diseases
Animals
Serologic Tests
Amino Acid Sequence
Immunoassays
Molecular Biology Techniques
Antibody-Producing Cells
Peptide Synthesis
Molecular Biology
Protozoan Infections
Blood Cells
Gene Mapping
Public Health
Environmental and Occupational Health

Organisms
Biology and Life Sciences
Proteins
lcsh:RA1-1270
Cell Biology
medicine.disease
biology.organism_classification
Tropical Diseases
Virology
030104 developmental biology
Epitope mapping
Visceral leishmaniasis
Amniotes
Immunologic Techniques
Epitope Mapping
Zdroj: PLoS Neglected Tropical Diseases, Vol 11, Iss 5, p e0005562 (2017)
PLoS Neglected Tropical Diseases
ISSN: 1935-2735
1935-2727
Popis: Background Leishmaniasis is one of the most important zoonotic diseases spread in Latin America. Since many species are involved in dog infection with different clinical manifestations, the development of specific diagnostic tests is mandatory for more accurate disease control and vaccine strategies. Methodology/Principal findings Seventy-five 15-mer peptides covering the sequence of recombinant Leishmania donovani virulence factor A2 (recLdVFA2) protein were prepared by Spot synthesis. Membrane-bound peptides immunoreactivity with sera from dogs immunized with recLdVFA2 and with a specific anti-recLdVFA2 monoclonal antibody allowed mapping of continuous B-cell epitopes. Five epitopes corresponding to the N-terminal region of recLdVFA2 (MKIRSVRPLVVLLVC, RSVRPLVVLLVCVAA, RPLVVLLVCVAAVLA, VVLLVCVAAVLALSA and LVCVAAVLALSASAE, region 1–28) and one located within the repetitive units (PLSVGPQAVGLSVG, regions 67–81 and 122–135) were identified. A 34-mer recLdVFA2-derived bi-epitope containing the sequence MKIRSVRPLVVLLVC linked to PLSVGPQAVGLSVG by a Gly-Gly spacer was chemically synthesized in its soluble form. The synthetic bi-epitope was used as antigen to coat ELISA plates and assayed with dog sera for in vitro diagnosis of canine visceral leishmaniasis (CVL). The assay proved to be highly sensitive (98%) and specific (99%). Conclusions/Significance Our work suggests that synthetic peptide-based ELISA strategy may be useful for the development of a sensitive and highly specific serodiagnosis for CVL or other parasitic diseases.
Author summary Leishmaniasis is a neglected tropical disease being among the six endemic prioritized diseases in the world. Visceral leishmaniasis (VL) is caused by Leishmania infantum and represents a serious public health problem in Brazil. Dogs are the main source of infection in the urban area and, in Brazil, the main strategies of the Visceral Leishmaniasis Control Program are directed to control the canine reservoir (serological survey and euthanasia of dogs which present reactive serum). In general, diagnosis of canine visceral leishmaniasis (CVL) has been presented as a problem for Brazilian public health services. The issue should be attributed mainly to the following factors: 1- range of similar clinical signs observed in other infectious diseases that affect dogs; 2- large percentage of asymptomatic or oligosymptomatic dogs; 3- nonspecific histopathological changes; 4- nonexistence of a diagnostic test 100% specific and sensitive. In this work, we developed a synthetic bi-epitope peptide as an antigen for immunodiagnostic ELISA to detect CVL. The biepitope used for ELISA assay accurately distinguish (98% sensitivity and 99% specificity) CVL dogs sera from non-infected dogs sera.
Databáze: OpenAIRE